Comparison of the efficacy of obinutuzumab versus rituximab combined with tacrolimus in the treatment of refractory membranous nephropathy

Abstract Background Primary membranous nephropathy (pMN) is characterized by a prolonged course, frequent relapses, and variable treatment responses. While obinutuzumab (OBI) demonstrates promising efficacy in B-cell depletion, its direct comparison with the combination regimen of rituximab (RTX) pl...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yulong Zhang, Mengnan Guo, Qi Bian, Shuangxi Li, Jing Sun, Zhenyu Qin, Jing Xu, Rui Dong
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMC 2026-05-01
Serie:	BMC Nephrology
Soggetti:	Refractory membranous nephropathy Obinutuzumab Rituximab Adverse events
Accesso online:	https://doi.org/10.1186/s12882-026-04958-2
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!